Your browser doesn't support javascript.
loading
Mutational analysis of TP53 gene in Tunisian familial hematological malignancies and sporadic acute leukemia cases.
Hamadou, Walid Sabri; Besbes, Sawsen; Bourdon, Violaine; Youssef, Yosra Ben; Laatiri, Mohamed Adnène; Noguchi, Testsuro; Khélif, Abderrahim; Sobol, Hagay; Soua, Zohra.
Afiliación
  • Hamadou WS; RU "Molecular Biology of Leukemias and Lymphomas", Laboratory of Biochemistry, Faculty of Medicine of Sousse, University of Sousse, Avenue Mohamed Karoui, 4000, Sousse, Tunisia. walid_sabrimail@yahoo.fr.
  • Besbes S; RU "Molecular Biology of Leukemias and Lymphomas", Laboratory of Biochemistry, Faculty of Medicine of Sousse, University of Sousse, Avenue Mohamed Karoui, 4000, Sousse, Tunisia.
  • Bourdon V; Department of Genetic Oncology, Prevention and Screening, Institute Paoli-Calmettes, Marseille, France.
  • Youssef YB; Service of Clinical Hematology, CHU Farhat Hached, Sousse, Tunisia.
  • Laatiri MA; Service of Clinical Hematology, CHU Fattouma Bourguiba, Monastir, Monastir, Tunisia.
  • Noguchi T; Department of Genetic Oncology, Prevention and Screening, Institute Paoli-Calmettes, Marseille, France.
  • Khélif A; Service of Clinical Hematology, CHU Farhat Hached, Sousse, Tunisia.
  • Sobol H; Department of Genetic Oncology, Prevention and Screening, Institute Paoli-Calmettes, Marseille, France.
  • Soua Z; RU "Molecular Biology of Leukemias and Lymphomas", Laboratory of Biochemistry, Faculty of Medicine of Sousse, University of Sousse, Avenue Mohamed Karoui, 4000, Sousse, Tunisia.
Fam Cancer ; 16(1): 153-157, 2017 01.
Article en En | MEDLINE | ID: mdl-27619989
ABSTRACT
Mutations are responsible for familial cancer syndromes which account for approximately 5-10 % of all types of cancers. Familial cancers are often caused by genetic alterations occurring either in tumor suppressor or genomic stability genes such as TP53. In this study, we have analyzed the TP53 gene by direct sequencing approach, in a panel of 18 Tunisian familial hematological malignancies cases including several forms of leukemia, lymphoma and myeloid syndrome and 22 cases of sporadic acute leukemia. In one familial case diagnosed with acute lymphoblastic leukemia, we reported an intronic substitution 559+1 G>A which may disrupt the splice site and impact the normal protein function. Most of the deleterious mutations (Arg158His; Pro282Trp; Thr312Ser) as classified by IARC data base, were commonly reported in ALL cases studied here. The cosegregation of the two variants rs1042522 and rs1642785 was observed in most patients which may be in favor of the presence of linkage disequilibrium. The most defined TP53 mutations found here were identified in acute lymphoblastic leukemia context whereas only 3 % of mutations have been in previous studies. The cosegregation of the two recurrent variant rs1042522 and rs1642785 should be further confirmed.
Asunto(s)
Palabras clave

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Leucemia / Proteína p53 Supresora de Tumor / Neoplasias Hematológicas / Mutación Límite: Humans País/Región como asunto: Africa Idioma: En Revista: Fam Cancer Asunto de la revista: NEOPLASIAS Año: 2017 Tipo del documento: Article País de afiliación: Túnez

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Leucemia / Proteína p53 Supresora de Tumor / Neoplasias Hematológicas / Mutación Límite: Humans País/Región como asunto: Africa Idioma: En Revista: Fam Cancer Asunto de la revista: NEOPLASIAS Año: 2017 Tipo del documento: Article País de afiliación: Túnez